推荐产品
生物源
mouse
品質等級
抗體表格
purified immunoglobulin
無性繁殖
521-5D, monoclonal
物種活性
human
製造商／商標名
Chemicon®
技術
ELISA: suitable
immunocytochemistry: suitable
immunohistochemistry (formalin-fixed, paraffin-embedded sections): suitable
同型
IgG
運輸包裝
wet ice
特異性
Human parvovirus B19. Recognizes amino acids 446-466 of VP2. Antibody inhibits haemagglutination.
免疫原
B-19 virus purified from an acute serum specimen from a child with aplastic crisis (Anderson, 1986).
應用
Immunoassay.
Immunocytochemistry
Optimal working dilutions must be determined by end user.
Immunocytochemistry
Optimal working dilutions must be determined by end user.
Research Category
Infectious Diseases
Infectious Diseases
Research Sub Category
Infectious Diseases - Viral
Infectious Diseases - Viral
This Anti-Parvovirus B19 Antibody, clone 521-5D is validated for use in ELISA, IC, IH, IH(P) for the detection of Parvovirus B19.
外觀
Format: Purified
Purified immunoglobulin. In 0.02M PB and 0.25M NaCl pH=7.6 with 0.1% NaN3 as a preservative.
儲存和穩定性
Maintain at 2-8°C in undiluted aliquots for up to 12 months
其他說明
Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.
法律資訊
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
免責聲明
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
儲存類別代碼
10 - Combustible liquids
水污染物質分類（WGK）
WGK 2
閃點（°F）
Not applicable
閃點（°C）
Not applicable
Recombinant parvovirus B19 empty capsids inhibit fetal hematopoietic colony formation in vitro.
B Lindton, T Tolfvenstam, O Norbeck, L Markling, O Ringden, M Westgren, K Broliden
Fetal Diagnosis and Therapy null
Placental cellular immune response in women infected with human parvovirus B19 during pregnancy.
Jordan, JA; Huff, D; DeLoia, JA
Clinical and Diagnostic Laboratory Immunology null
Human parvovirus B19 infection in acute fulminant liver failure.
Y V Karetnyi, P R Beck, R S Markin, A N Langnas, S J Naides
Archives of Virology null
L Skjöldebrand-Sparre et al.
BJOG : an international journal of obstetrics and gynaecology, 107(4), 476-480 (2000-04-12)
To identify the presence of parvovirus B19 infection as a possible cause of fetal loss in the third trimester. Prospective study of women experiencing third-trimester intrauterine fetal death (IUFD). All cases of IUFD at Danderyd Hospital from 1992 to 1998.
Laura A Adamson et al.
Journal of medical virology, 86(9), 1614-1620 (2013-11-23)
Human erythrovirus B19 (EVB19) is a small, pathogenic DNA virus that has been associated with a wide range of illnesses. The primary site of replication is in bone marrow-derived erythroid progenitor cells, but EVB19 DNA has been detected in a
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门